Prescribing Culture, Severity Adjustment, and Outcome Choice in Dexamethasone Regimen Studies for Pediatric Asthma Exacerbations
When deciding between a single versus double dose of dexamethasone for an acutely ill child with asthma, remember that the evidence suggests similar weighted risks for 14-day readmission or revisit regardless of which regimen is used. While practice variation exists, you can proceed with either dosing strategy without significant added concern regarding short-term outcomes based on this data. Always consider local resource availability and patient adherence when making your final decision.
This article reviews a recent comparison examining the efficacy of one versus two doses of dexamethasone in managing pediatric asthma exacerbations treated in the emergency department setting. The authors highlight that there is significant practice variation regarding whether to administer a single dose or a more robust two-dose regimen upon discharge. Crucially, their analysis found that despite nearly two-thirds of children receiving the two-dose approach, the weighted risks for both 14-day ED revisit and subsequent hospitalization were comparable between the one-dose and two-dose groups. This suggests that current clinical guidelines or standard practice may not be driving a measurable difference in short-term outcomes based on this dosing strategy.